GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jagsonpal Pharmaceuticals Ltd (BOM:507789) » Definitions » Other Income (Expense)

Jagsonpal Pharmaceuticals (BOM:507789) Other Income (Expense) : ₹279 Mil (TTM As of Mar. 2025)


View and export this data going back to 1991. Start your Free Trial

What is Jagsonpal Pharmaceuticals Other Income (Expense)?

Jagsonpal Pharmaceuticals's other income expense for the Jagsonpal Pharmaceuticals's pretax income for the three months ended in Mar. 2025 was ₹26 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₹279 Mil.

Jagsonpal Pharmaceuticals Other Income (Expense) Historical Data

The historical data trend for Jagsonpal Pharmaceuticals's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jagsonpal Pharmaceuticals Other Income (Expense) Chart

Jagsonpal Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.07 8.36 -25.37 92.79 278.77

Jagsonpal Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.87 -18.41 16.54 255.06 25.58

Jagsonpal Pharmaceuticals Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹279 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jagsonpal Pharmaceuticals  (BOM:507789) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Jagsonpal Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jagsonpal Pharmaceuticals Ltd (BOM:507789) » Definitions » Other Income (Expense)
Comparable Companies
BOM:524470 BOM:543389 BOM:524669 NSE:BETA BOM:539872 BOM:590006 BOM:524164 BOM:506197 BOM:530199 BOM:500672 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
JAGSNPHARM:India
Address
3rd Floor, Phase – IV, Udyog Vihar, Plot No. 412-415, Nimai Tower, Gurugram, HR, IND, 122015
Website
https://www.jagsonpal.com
Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company. It develops and manufactures active pharmaceutical ingredients and formulations like Capsule and Tablet. The company operates in the Gynaecology, Orthopaedics, Dermatology and Paediatric segments. Its brands comprise Lycored, Maintane, Metadec, Metabol, Doxypal DR, and others.

Jagsonpal Pharmaceuticals Headlines

No Headlines